BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1507729)

  • 1. [Clinical analysis of multiple primary cancers associated with bladder cancer].
    Takahashi S; Sugimoto M; Shinohara M; Kinoshita K
    Nihon Hinyokika Gakkai Zasshi; 1992 Jul; 83(7):1118-23. PubMed ID: 1507729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple primary cancers (MPC) associated with bladder cancer: an analysis of the clinical and autopsy cases in Japan.
    Kotake T; Kiyohara H
    Jpn J Clin Oncol; 1985 Apr; 15 Suppl 1():201-10. PubMed ID: 4009982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical features of multiple primary cancers including prostate cancer].
    Nakata S; Takahashi H; Takezawa Y; Kobayashi M; Suzuki T; Kawashima K
    Hinyokika Kiyo; 2000 Jun; 46(6):385-91. PubMed ID: 10934606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study.
    Samaratunga H; Khoo K
    Histopathology; 2004 Jul; 45(1):55-64. PubMed ID: 15228444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative Management of Multiple Primary Cancers Associated with Non-small Cell Lung Cancer.
    Shoji F; Yamazaki K; Miura N; Katsura M; Oku Y; Takeo S; Maehara Y
    Anticancer Res; 2018 Jun; 38(6):3773-3778. PubMed ID: 29848742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical analysis of 121 cases of urothelial carcinoma accompanied with multiple primary carcinoma].
    Gu YC; Ye JF; Cao BS; Wang MP; Ma LL; Ma LW
    Zhonghua Zhong Liu Za Zhi; 2019 Oct; 41(10):760-764. PubMed ID: 31648498
    [No Abstract]   [Full Text] [Related]  

  • 7. Multiple primary cancers in patients with gastric cancer.
    Wu CW; Lo SS; Chen JH; Hsieh MC; Li AF; Lui WY
    Hepatogastroenterology; 2006; 53(69):463-7. PubMed ID: 16795993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Risk of Developing Multiple Primary Cancers among Long-Term Survivors Five Years or More after Stomach Carcinoma Resection.
    Amikura K; Ehara K; Kawashima Y
    Tohoku J Exp Med; 2020 Jan; 250(1):31-41. PubMed ID: 31969528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical features of patients with head and neck malignant tumor concurrent with multiple primary carcinoma].
    Zhang XX; Yan F; Liu MB; Wang JL; Wu WM; Ma L; Huang DL
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jul; 51(7):491-6. PubMed ID: 27480296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple primary cancers associated with esophageal carcinoma.
    Kumagai Y; Kawano T; Nakajima Y; Nagai K; Inoue H; Nara S; Iwai T
    Surg Today; 2001; 31(10):872-6. PubMed ID: 11759880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological analysis of site relationships of synchronous and metachronous multiple primary cancers in the National Cancer Center, Japan, 1962-1996.
    Kaneko S; Yamaguchi N
    Jpn J Clin Oncol; 1999 Feb; 29(2):96-105. PubMed ID: 10089951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological features and prognostic analysis of 77 patients with multiple primary cancers.
    Zheng R; Li H; Ye Y; Guan L; Li H; Ye Z; Yuan G; Zhang X; Wang G; Cao M; Zhang R; Jiang B
    J BUON; 2020; 25(4):2110-2116. PubMed ID: 33099961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
    Solsona E; Iborra I; Ricos JV; Monros JL; Rubio J; Almenar S
    J Urol; 2002 May; 167(5):2007-11. PubMed ID: 11956428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinicopathological characteristics of micropapillary variant of urinary bladder carcinoma].
    Radulović P; Pavić I; Marusić Z; Perić-Balja M; Znaor A; Kraus O; Kruslin B
    Lijec Vjesn; 2008; 130(1-2):1-3. PubMed ID: 18589634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate.
    Frazier HA; Robertson JE; Dodge RK; Paulson DF
    Cancer; 1993 Jun; 71(12):3993-4001. PubMed ID: 8508365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic features of metachronous or synchronous gastric cancer patients with three or more primary sites.
    Kim JH; Rha SY; Kim C; Kim GM; Yoon SH; Kim KH; Kim MJ; Ahn JB; Chung HC; Roh JK; Kim HS
    Cancer Res Treat; 2010 Dec; 42(4):217-24. PubMed ID: 21253324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relevance of prostate cancer in patients with synchronous invasive bladder urothelial carcinoma: a monocentric retrospective analysis.
    Dell'Atti L
    Arch Ital Urol Androl; 2015 Mar; 87(1):76-9. PubMed ID: 25847902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second primary cancers in the Vaud and Neuchâtel Cancer Registries.
    Levi F; Randimbison L; Rafael BM; Manuela MC; La Vecchia C
    Eur J Cancer Prev; 2015 Mar; 24(2):150-4. PubMed ID: 25397586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.